Our previous studies uncovered that SHCBP1 is a novel downstream target gene of SS18-SSX1, who acts as an oncogene by promoting proliferation and tumorigenicity of SS cells [24]. The gene discussed is SHCBP1; the disease is synovial sarcoma.